
Ridge Diagnostics offers proprietary blood tests for depression, leveraging unique biomarker technology.
Founded in North Carolina, Ridge Diagnostics is a neurodiagnostic company with a core mission to revolutionize the diagnosis and treatment of Major Depressive Disorder (MDD) through innovative blood tests. Utilizing its proprietary Human Biomarker Library and Biomarker Hyper-Map™ technology platform, the company has developed multi-variant biological marker assays and diagnostic algorithms. These advancements enable more precise and effective management of depression, addressing a significant need in mental health care.
Ridge Diagnostics operates a CLIA-certified laboratory, ensuring high standards in clinical testing. The company has garnered attention from notable investors and medical professionals who recognize the potential impact of its technology. Key achievements include the successful development and commercialization of its first-in-class blood test for MDD. Ridge Diagnostics' work has significantly advanced the field of neurodiagnostics, offering new hope for patients and clinicians in the battle against depression.

Babson Diagnostics
babsondx.com

SynapDx

FYR Diagnostics
fyrdiagnostics.com

Instadiagnostics

Nowdiagnostics
nowdx.com

Test Diagnostics

Eclipse Diagnostics

Chosen Diagnostics

TAI Diagnostics

Prompt Diagnostics
prompt-dx.com

Empowered Diagnostics

BioChip Labs
biochiplabs.com

Iv Diagnostics

FBB Biomed
fbbbio.com

Truvian
truvianhealth.com
Companies similar to Ridge Diagnostics include Babson Diagnostics, SynapDx, FYR Diagnostics and Instadiagnostics.
Ridge Diagnostics was founded in 2006.
Ridge Diagnostics' headquarters is located in Los Angeles, CA, US.
Ridge Diagnostics' most recent funding round was for $250k (USD) in April 2013.
As of Apr 18, 2013, Ridge Diagnostics has raised a total of $827k (USD).
Ridge Diagnostics has 11 employees as of Feb 5, 2024.